Canton Strategic Holdings, Inc. (CNTN) stock
Close on Nov 12, 2026Market cap $143.43MP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $143.43M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.32
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$98.12M
- EPS, diluted
- -$1.12
- Book value per share
- $2.10
- Diluted shares
- 217M
Trading
- Previous close
- $1.95
- Open
- $1.89
- Day's range
- $1.80 – $1.93
- Volume
- 931,650
- Average volume (20 days)
- 661,844
- Index membership
- Russell 2000 (since Jun 2026)
- Beta (5 years)
- 0.45
- 52-week range
- $1.66 – $5.83
- RSI (14 days)
- 43.3
- Volatility (1 year)
- 90.4%
- Relative volume
- 1.25×
- WACC
- 7.4%
Index membership is inferred from the holdings of funds that track each index (IWM), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2022, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | CNTN | S&P 500 | Difference | CNTN per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -14.7% | -2.7% | −12.0 pts | ||
| 3 months | -8.6% | -1.7% | −6.9 pts | ||
| Year to date | -40.6% | +11.9% | −52.5 pts | ||
| 1 year | -44.1% | +12.0% | −56.1 pts | ||
| 3 years | -97.4% | +78.2% | −175.6 pts | -70.6% | +21.2% |
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Operating income
Net income
EPS, diluted
Press releases
Releases Canton Strategic filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Results
- News
- News
- Update
About Canton Strategic
Finance Services
Canton Strategic Holdings, Inc. is an enterprise focused on digital asset treasury operations and clinical-stage biotechnology development. The company conducts business through two main operational segments: digital asset treasury management and biotechnology research. Within its digital asset segment, the organization holds Canton Coin, operates as a network validator, and supports the Canton Network to foster institutional blockchain adoption and the digitization of financial markets. In its biotechnology business, it develops drug candidates targeted at inflammatory and immunologic conditions characterized by significant unmet medical need. Because its pharmaceutical pipeline remains in clinical development and its digital asset activities center on network participation and balance sheet management, the filing identifies no commercial customers.
Company profile, executives and historyCanton Strategic stock: common questions
What is Canton Strategic's stock price?
CNTN closed at $1.80 on Nov 12, 2026, down 7.69% on the day. Over the past 52 weeks it traded between $1.66 and $5.83.
What is Canton Strategic's market cap?
Canton Strategic was worth $143.43M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is CNTN's P/E ratio?
Canton Strategic lost money over fiscal 2025 (diluted EPS -$1.12), so it has no meaningful P/E ratio.
Does Canton Strategic pay a dividend?
No. Canton Strategic has not paid a cash dividend over the last twelve months.
How has CNTN stock performed over the past year?
Including dividends, CNTN returned -44.1% over the past year, against +12.0% for the S&P 500.
How many CNTN shares are sold short?
8M shares were sold short at the latest FINRA report, 10.37% of the float, or 12.6 days of average trading volume.
Who are Canton Strategic's competitors?
Companies most similar to Canton Strategic by business, industry and size include LITS, USBC, HSDT, HYPD, BTCS.
See a number that looks wrong?